- Home
- KLTR vs CKPT Comparison
KLTR vs CKPT Comparison
Compare KLTR & CKPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTR
- CKPT
- Stock Information
- Founded
- KLTR 2006
- CKPT 2014
- Country
- KLTR United States
- CKPT United States
- Employees
- KLTR N/A
- CKPT N/A
- Industry
- KLTR EDP Services
- CKPT Biotechnology: Pharmaceutical Preparations
- Sector
- KLTR Technology
- CKPT Health Care
- Exchange
- KLTR Nasdaq
- CKPT Nasdaq
- Market Cap
- KLTR 319.1M
- CKPT 361.1M
- IPO Year
- KLTR 2021
- CKPT 2017
- Fundamental
- Price
- KLTR $2.21
- CKPT N/A
- Analyst Decision
- KLTR Buy
- CKPT Buy
- Analyst Count
- KLTR 3
- CKPT 3
- Target Price
- KLTR $2.83
- CKPT $4.33
- AVG Volume (30 Days)
- KLTR 304.8K
- CKPT 2.1M
- Earning Date
- KLTR 05-08-2025
- CKPT 05-13-2025
- Dividend Yield
- KLTR N/A
- CKPT N/A
- EPS Growth
- KLTR N/A
- CKPT N/A
- EPS
- KLTR N/A
- CKPT N/A
- Revenue
- KLTR $180,920,000.00
- CKPT $41,000.00
- Revenue This Year
- KLTR $3.46
- CKPT $102,182.93
- Revenue Next Year
- KLTR $3.67
- CKPT $351.71
- P/E Ratio
- KLTR N/A
- CKPT N/A
- Revenue Growth
- KLTR 2.40
- CKPT N/A
- 52 Week Low
- KLTR $0.76
- CKPT $1.80
- 52 Week High
- KLTR $2.82
- CKPT $4.50
- Technical
- Relative Strength Index (RSI)
- KLTR 55.44
- CKPT 3.56
- Support Level
- KLTR $2.10
- CKPT $4.14
- Resistance Level
- KLTR $2.28
- CKPT $4.28
- Average True Range (ATR)
- KLTR 0.09
- CKPT 0.02
- MACD
- KLTR -0.00
- CKPT -0.50
- Stochastic Oscillator
- KLTR 71.11
- CKPT 0.00
About KLTR Kaltura Inc.
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.
About CKPT Checkpoint Therapeutics Inc.
Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.